Results
1
High Growth Stocks
1 companies
argenx
Market Cap: €47.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€758.40
7D
1.0%
1Y
55.3%
